On-demand education

Bladder Cancer
Type

Dr. Richard Cathomas about Immunotherapy in muscle-invasive bladder cancer

Duration: 12 minutes

New insights in treatment of bladder cancer: From localised to metastatic diseases

Duration: 60

Patient stratification and risk related treatment of NMIBC

Duration: Approx. 60 minutes

Artificial intelligence: The role for research and patient treatment

Duration: Approx. 70 minutes

Bladder cancer TURB

Duration: Approx. 60 – 90 minutes

Developments in perioperative immunotherapy for bladder and kidney cancers

Duration: Approx. 70 minutes

Renal, bladder and prostate cancer guidelines 2021: From guidelines to real world

Duration: Approx. 60 minutes

BCG unresponsive disease how this definition impact your treatment decision making

Duration: Approx. 60 – 90 minutes

Practical management of bladder cancer

Duration: Approx. 60 minutes

New treatments development in NMIBC

Duration: Approx. 45 minutes

Time to Cystectomy: Patients' perspective

Duration: Approx. 45 minutes

Is immune therapy changing the way we think about early bladder cancer?

Duration: Approx. 40 minutes

EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer

Duration: Approx. 60 – 90 minutes

EAU Guidelines on Primary Urethral Carcinoma

Duration: Approx. 60 – 90 minutes

EAU Guidelines on Non-muscle Invasive Bladder Cancer

Duration: Approx. 60 – 90 minutes

Non-Muscle-Invasive Bladder Cancer

Duration: Approx. 120 minutes